跳至主要内容
临床试验/NCT00399737
NCT00399737终止1 期

Effects of Peptides Derived From Fermented Milk on Blood Pressure Regulation System in Healthy Volunteers.

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2005年10月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
12
试验地点
1
主要终点
ACE activity

研究概览

简要总结

Several milk proteins are precursors of peptides, released during fermentation, which possess various biochemical and physiological properties. Among them, some peptides have been reported to inhibit angiotensin-converting enzyme (ACE) in vitro (an enzyme implicated in blood pressure regulation) and to lower blood pressure (BP). in hypertensive rats and in a small sample of patients with hypertension. One possible mechanism for the BP lowering effect is inhibition of ACE. Prior investigating BP lowering effect of these peptides in a large cohort of hypertensive patients, it is necessary to assess in depth their potency to inhibit ACE in vivo in humans and to compare it to that induced by a well-known ACE inhibitor.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Healthy male volunteers
  • •aged between 18 and 35 years
  • •informed written consent

排除标准

  • 未提供

结局指标

主要结局

ACE activity

次要结局

  • kinetics/dynamics

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验